In this context, it is worth to note that AA-containing plasmalogens have been previously identified as markers of healthy obesity44 and that plasmalogen supplementation has been shown to attenuate atherosclerosis development in apoE-deficient mice.48 The gene discussed is APOE; the disease is atherosclerosis.